IRPC PCL (TPIG) - Net Assets
Based on the latest financial reports, IRPC PCL (TPIG) has net assets worth €65.99 Billion EUR (≈ $77.15 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€187.38 Billion ≈ $219.07 Billion USD) and total liabilities (€121.39 Billion ≈ $141.92 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check IRPC PCL tangible book value ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €65.99 Billion |
| % of Total Assets | 35.22% |
| Annual Growth Rate | -3.93% |
| 5-Year Change | -24.77% |
| 10-Year Change | N/A |
| Growth Volatility | 8.19 |
IRPC PCL - Net Assets Trend (2018–2025)
This chart illustrates how IRPC PCL's net assets have evolved over time, based on quarterly financial data. See IRPC PCL (TPIG) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for IRPC PCL (2018–2025)
The table below shows the annual net assets of IRPC PCL from 2018 to 2025. For live valuation and market cap data, see how much is IRPC PCL worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €65.99 Billion ≈ $77.15 Billion |
-5.88% |
| 2024-12-31 | €70.11 Billion ≈ $81.96 Billion |
-7.90% |
| 2023-12-31 | €76.12 Billion ≈ $88.99 Billion |
-4.46% |
| 2022-12-31 | €79.68 Billion ≈ $93.15 Billion |
-9.16% |
| 2021-12-31 | €87.71 Billion ≈ $102.54 Billion |
+15.92% |
| 2020-12-31 | €75.67 Billion ≈ $88.46 Billion |
-9.28% |
| 2019-12-31 | €83.40 Billion ≈ $97.51 Billion |
-4.55% |
| 2018-12-31 | €87.38 Billion ≈ $102.16 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to IRPC PCL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 58.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €15.16 Billion | 23.02% |
| Other Components | €50.72 Billion | 76.98% |
| Total Equity | €65.88 Billion | 100.00% |
IRPC PCL Competitors by Market Cap
The table below lists competitors of IRPC PCL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yugo Metals Limited
AU:YUG
|
$541.95 |
|
TMBThanachart Bank Public Company Limited
F:TMLF
|
$566.49 |
|
Ordinary Fully Paid Deferred Settlement
AU:RC1DC
|
$567.74 |
|
Isomet Corp
NASDAQ:IOMT
|
$567.98 |
|
Biocept Inc.
NASDAQ:BIOCQ
|
$525.00 |
|
HighPeak Energy Inc
NASDAQ:HPKEW
|
$494.40 |
|
China Auto Logistics Inc
NASDAQ:CALI
|
$484.00 |
|
Ricardo
LSE:RCDO
|
$480.86 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in IRPC PCL's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 69,966,033,647 to 65,882,017,277, a change of -4,084,016,370 (-5.8%).
- Net loss of 3,571,429,576 reduced equity.
- Dividend payments of 204,098,823 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-3.57 Billion | -5.42% |
| Dividends Paid | €204.10 Million | -0.31% |
| Other Changes | €-308.49 Million | -0.47% |
| Total Change | €- | -5.84% |
Book Value vs Market Value Analysis
This analysis compares IRPC PCL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €21.38 | €0.05 | x |
| 2019-12-31 | €20.40 | €0.05 | x |
| 2020-12-31 | €3.70 | €0.05 | x |
| 2021-12-31 | €4.29 | €0.05 | x |
| 2022-12-31 | €3.89 | €0.05 | x |
| 2023-12-31 | €3.72 | €0.05 | x |
| 2024-12-31 | €3.43 | €0.05 | x |
| 2025-12-31 | €3.23 | €0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently IRPC PCL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.42%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.28%
- • Asset Turnover: 1.49x
- • Equity Multiplier: 2.84x
- Recent ROE (-5.42%) is below the historical average (-2.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 8.86% | 2.76% | 1.54x | 2.09x | €-993.62 Million |
| 2019 | -13.39% | -5.57% | 1.13x | 2.14x | €-19.48 Billion |
| 2020 | -8.15% | -3.53% | 1.01x | 2.30x | €-13.70 Billion |
| 2021 | 16.58% | 5.69% | 1.34x | 2.18x | €5.76 Billion |
| 2022 | -5.49% | -1.34% | 1.64x | 2.49x | €-12.31 Billion |
| 2023 | -3.85% | -0.92% | 1.66x | 2.54x | €-10.51 Billion |
| 2024 | -7.42% | -1.65% | 1.71x | 2.64x | €-12.19 Billion |
| 2025 | -5.42% | -1.28% | 1.49x | 2.84x | €-10.16 Billion |
Industry Comparison
This section compares IRPC PCL's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.
About IRPC PCL
IRPC PCL operates in various business sectors.